HEMOGENYX PHARMPLC (Germany) Buy Hold or Sell Recommendation
5HU Stock | EUR 3.98 0.08 2.05% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding HEMOGENYX PHARMPLC LS 01 is 'Not Rated'. Macroaxis provides HEMOGENYX PHARMPLC buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 5HU positions.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Note, we conduct extensive research on individual companies such as HEMOGENYX and provide practical buy, sell, or hold advice based on investors' constraints. HEMOGENYX PHARMPLC LS 01. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
HEMOGENYX |
Execute HEMOGENYX PHARMPLC Buy or Sell Advice
The HEMOGENYX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on HEMOGENYX PHARMPLC LS 01. Macroaxis does not own or have any residual interests in HEMOGENYX PHARMPLC LS 01 or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute HEMOGENYX PHARMPLC's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
![]() | ![]() |
Not Rated
HEMOGENYX PHARMPLC Trading Alerts and Improvement Suggestions
HEMOGENYX PHARMPLC is not yet fully synchronised with the market data | |
HEMOGENYX PHARMPLC is way too risky over 90 days horizon | |
HEMOGENYX PHARMPLC appears to be risky and price may revert if volatility continues | |
Net Loss for the year was (2.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations. | |
Roughly 15.0% of the company shares are owned by insiders or employees |
HEMOGENYX PHARMPLC current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. HEMOGENYX analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. HEMOGENYX analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
HEMOGENYX PHARMPLC Returns Distribution Density
The distribution of HEMOGENYX PHARMPLC's historical returns is an attempt to chart the uncertainty of HEMOGENYX PHARMPLC's future price movements. The chart of the probability distribution of HEMOGENYX PHARMPLC daily returns describes the distribution of returns around its average expected value. We use HEMOGENYX PHARMPLC LS 01 price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of HEMOGENYX PHARMPLC returns is essential to provide solid investment advice for HEMOGENYX PHARMPLC.
Mean Return | 1.57 | Value At Risk | -22.22 | Potential Upside | 23.08 | Standard Deviation | 20.33 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of HEMOGENYX PHARMPLC historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
HEMOGENYX PHARMPLC Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as HEMOGENYX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About HEMOGENYX PHARMPLC Buy or Sell Advice
When is the right time to buy or sell HEMOGENYX PHARMPLC LS 01? Buying financial instruments such as HEMOGENYX Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having HEMOGENYX PHARMPLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Makers Thematic Idea Now
Chemicals Makers
Companies developing chemicals for crops, soil as well as human, and animals. The Chemicals Makers theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Makers Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in HEMOGENYX Stock
HEMOGENYX PHARMPLC financial ratios help investors to determine whether HEMOGENYX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HEMOGENYX with respect to the benefits of owning HEMOGENYX PHARMPLC security.